Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Cisplatin × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 128 Squamous Cell Carcinoma of Head and Neck 80 Lung Neoplasms 47 Head and Neck Neoplasms 44 Urinary Bladder Neoplasms 40 Parkinson Disease 4, Autosomal Dominant Lewy Body 31 Uterine Cervical Neoplasms 30 Oropharyngeal Neoplasms 29 Nasopharyngeal Carcinoma 28 Biliary Tract Neoplasms 28 Neoplasms 25 Cholangiocarcinoma 25 Esophageal Squamous Cell Carcinoma 23 Carcinoma 23 Ovarian Neoplasms 22 Neoplasm Metastasis 22 Carcinoma, Squamous Cell 21 Colorectal Neoplasms 20 Stomach Neoplasms 18 Esophageal Neoplasms 17 Carcinoma, Transitional Cell 17 Mesothelioma, Malignant 15 Gallbladder Neoplasms 15 Small Cell Lung Carcinoma 14 Pancreatic Neoplasms 13 Mouth Neoplasms 13 Laryngeal Neoplasms 13 Hypopharyngeal Neoplasms 12 Recurrence 10 Melanoma 10

Interventions

pembrolizumab 19 Nivolumab 12 avelumab 10 Ipilimumab 7 cemiplimab 5 atezolizumab 5 Specimen Handling 5 Biopsy 5 Magnetic Resonance Spectroscopy 4 Radiotherapy 3 Cyclophosphamide 3 prednylidene 2 poly ICLC 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 deltacortene 2 aldesleukin 2 Radiosurgery 2 Prednisone 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 CTLA-4 Antigen 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05594290 2026-01-14

MERCURY

Gruppo Oncologico del Nord-Ovest

Phase 2 Active not recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡